Sensus Healthcare (SRTS) Cash from Operations Growth (1y) (2018 - 2026)
Sensus Healthcare (SRTS) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 122.43% |
| 10 | Sensus Healthcare | 49.96 Mn | 31.64 Mn | - | -40.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.19% |
| Dec 31, 2025 | -166.87% |
| Sep 30, 2025 | -41.94% |
| Jun 30, 2025 | -26.31% |
| Mar 31, 2025 | 67.30% |
| Dec 31, 2024 | -131.00% |
| Sep 30, 2024 | 794.34% |
| Jun 30, 2024 | 470.08% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | 126.38% |
| Sep 30, 2023 | -88.13% |
| Jun 30, 2023 | -60.86% |
| Mar 31, 2023 | -294.58% |
| Dec 31, 2022 | -468.15% |
| Sep 30, 2022 | 197.13% |
| Jun 30, 2022 | 39.82% |
| Mar 31, 2022 | 376.41% |
| Dec 31, 2021 | -394.44% |
| Sep 30, 2021 | 147.44% |
| Jun 30, 2021 | -36.43% |